Ariosa Diagnostics, Inc. v. Sequenom, Inc., 788 F.3d 1371 (Fed. Cir. 2015), is a controversial decision of the US Federal Circuit in which the court applied...
30 KB (3,887 words) - 22:30, 14 October 2024
the "540 patent" (US 6258540 ). The cases are Sequenom Inc. v. Natera Inc. 12-cv-0184, Sequenom v. Ariosa Diagnostics Inc., 12-cv-0189, U.S. District Court...
22 KB (1,978 words) - 02:12, 1 September 2024
(Gottschalk v. Benson, Parker v. Flook), but their new and useful applications may be patentable (Diamond v. Diehr). The Mayo, Myriad and Ariosa v. Sequenom patents...
53 KB (6,641 words) - 18:41, 7 August 2024
corresponding to the fetus's father in the blood of pregnant women in Ariosa v. Sequenom), a patent will be denied, as not meeting statutory subject matter...
29 KB (3,675 words) - 07:02, 13 December 2023
Collaborative Services v. Prometheus Laboratories, Inc., or that pregnant woman's blood contains DNA of fetus' father as in Ariosa v. Sequenom) is not patent-ineligible...
36 KB (4,052 words) - 16:34, 20 October 2024
Association for Molecular Pathology v. Myriad Genetics, Inc. DDR Holdings, LLC v. Hotels.com Ariosa v. Sequenom Genetic Technologies v. Merial patent-eligibility...
33 KB (3,847 words) - 17:03, 8 June 2024
adopting Judge Newman's position. In 2015 Newman wrote a dissent in Ariosa v. Sequenom that criticized Federal Circuit's holding on patent-eligible subject...
35 KB (3,789 words) - 08:52, 27 October 2024
controversy, as discussed in Mayo v. Prometheus and Ariosa v. Sequenom. The subsequent opinion of the Supreme Court in Alice Corp. v. CLS Bank International confirmed...
17 KB (2,356 words) - 02:52, 13 September 2023